Journal

Targeted Oncology

1776-2596 · Springer Science and Business Media LLC

104 verified public works

Browse all journals →

Beyond Contraindication-Based Selection: The Unmet Need for Predictive Biomarkers in First-Line Immunotherapy for Advanced HCC

2026 · 0 citations

Prevalence of PD-L1-High Tumor Expression and Association with First-Line Treatment Outcomes in Patients with Metastatic Urothelial Carcinoma: Results from a Prospective Observational Cohort Study

2026 · 0 citations

Correction: Regorafenib as Second-Line Versus Later-Line Therapy in Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study with Exploratory Analysis of Prior Immune Checkpoint Inhibitor Exposure

2026 · 0 citations

Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer

2026 · 0 citations

Successful treatment of brain metastases from renal cell cancer using radiotherapy in combination with sorafenib

2008 · 0 citations

Management of skin toxicity of epidermal growth factor receptor inhibitors

2008 · 0 citations

Mechanisms of resistance to EGFR tyrosine kinase inhibitors: implications for patient selection and drug combination strategies

2008 · 0 citations

Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report

2008 · 0 citations

Functional inactivation of CD4+CD25high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity

2008 · 0 citations

Update on targeted therapies for small cell carcinoma of the lung

2008 · 0 citations

EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: how do we interpret the clinical and biomarker data?

2008 · 0 citations

The role of positron emission tomography in staging of non-small cell lung cancer

2008 · 0 citations

Antiangiogenic treatments of advanced non-small cell lung cancer

2008 · 0 citations

Targeted therapies in bronchioloalveolar carcinoma

2008 · 0 citations

Targeted therapy in the management of lung cancer: is there more hype than hope?

2008 · 0 citations

Pharmacogenetics in lung cancer for the lay doctor

2008 · 0 citations

Targeted therapy in malignant mesothelioma

2008 · 0 citations

Advanced non-small cell lung cancer therapy: historical and future perspectives

2008 · 0 citations

Targeted agents in gastrointestinal cancer: a reality in clinical practice

2008 · 0 citations

A new functional imaging technique for the early functional evaluation of antiangiogenic treatment: dynamic contrast-enhanced ultrasonography (DCE-US)

2008 · 0 citations

The role of biologics in stomach cancer

2008 · 0 citations

Rationale for targeted therapies in hepatocellular carcinoma

2008 · 0 citations

Can we predict the response to epidermal growth factor receptor targeted therapy?

2008 · 0 citations

Imaging and targeted agents in gastrointestinal cancers: overview on perfusion- and diffusion-weighted magnetic resonance imaging and angiogenesis inhibitors

2008 · 0 citations

What is the impact of biologicals in colorectal cancer?

2008 · 0 citations

Targeted therapies and surgical issues in gastrointestinal cancers

2008 · 0 citations

Controversial evaluation of EGFR protein and gene status in predicting response to anti-EGFR monoclonal antibodies in metastatic colorectal cancer: a case report and review of the literature

2008 · 0 citations

New therapies in squamous cell carcinoma of the head and neck: is the future in combined therapies?

2008 · 0 citations

Optimizing antiangiogenic strategies: combining with radiotherapy

2008 · 0 citations

Phase I and pharmacokinetic study of vatalanib plus capecitabine in patients with advanced cancer

2007 · 0 citations